Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division focused on AI-enabled preventive care and longevity screening. 

The rebrand reflects a broader strategic evolution in SimonMed’s approach to patient care, leveraging AI to expand its focus in including earlier risk identification and preventive support, alongside extensive diagnostic services. 

Jan. 27, 2026 — QT Imaging and Olea Medical have announced plans to collaborate. This collaboration enhances QT Imaging’s Cloud SaaS Platform by integrating Olea Medical’s advanced visualization, quantitative analytics and AI-ready imaging technologies to support clinical interpretation, research workflows and quantitative imaging analysis.

The Olea collaboration builds on QT Imaging’s existing cloud infrastructure, to be delivered through InteleShare platform, which provides the enterprise PACS and cloud backbone for QT Imaging’s clinical and research deployments.

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, recently announced that U.S. Patent No. 12,527,885 has been granted by the United States Patent and Trademark Office (USPTO). This strengthens and extends the scope of the intellectual property portfolio for Nuclidium’s NU101 radiotheranostic program. The patent protects the Copper-61 based diagnostic as well as its use in combination with the Copper-67 based therapeutic in a theranostic setting.

Jan. 26, 2026 — Researchers at the University of Arizona were awarded up to $1.8 million by the Advanced Research Projects Agency for Health, or ARPA-H, an agency within the U.S. Department of Health and Human Services, to develop a lymphatic scanner small and light enough for physicians to bring with them to diagnose and monitor patients with lymphatic disease.

Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first comprehensive AI triage solution1,2, enabling health systems to surface critical findings earlier and reduce delays in patient flow amid Emergency Department (ED) crowding and imaging backlogs. This was made possible by CARE, Aidoc's self-developed AI foundation model.

Jan. 22, 2026 —  Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal database to further advance future prevention and identification innovations.

Jan. 11, 2026 — The Global Refurbished Medical Imaging Equipment Market Size is projected to grow at a CAGR of 15.07% from 2026 to 2032, according to a new report published by Verified Market Research. The report reveals that the market was valued at $12,990.44 million in 2024 and is expected to reach $40,056.03 million by the end of the forecast period.

Market Overview

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full-body radiation protection systems for interventional medicine practitioners, has announced the positive results of the NOVARAD clinical study. This study, the first ever in the world to evaluate exposure to X-rays in interventional neuroradiology, aimed at assessing the effectiveness of Nova-X in protecting from head to toe the whole staff team in cath labs from exposure to X-rays during interventional procedures.

Jan. 21, 2026 — Fujifilm Healthcare Americas Corp. and Voicebrook, Inc. have announced a strategic partnership to integrate Voicebrook’s VoiceOver PRO reporting platform with Fujifilm’s Synapse Pathology, a comprehensive pathology PACS that streamlines case management through proprietary advances in image digitization. This collaboration brings together comprehensive digital-pathology capabilities and voice-driven reporting workflows to help laboratories modernize operations, reduce manual steps, and accelerate pathology turnaround.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now